Covid-19 patients who were given the low-cost antidepressant fluvoxamine were significantly less likely to require hospitalization
Patients who received the low-cost and widely available drug were far less likely to be hospitalized in a clinical trial
Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ
Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer: